MedPath

Clinical Evaluation of Vishtindukadi Vati and Mansayadi Kwath Along With Abhyang In Management of Opium Addictio

Phase 2
Conditions
Health Condition 1: F112- Opioid dependence
Registration Number
CTRI/2022/12/048153
Lead Sponsor
niversity Post Graduate Institute of Aurved Studies and Research Jodhpur Rajathan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosed patients of opium addiction.

2.Age between 20-50 years.

3.Patient willing to give consent for clinical trial.

4.Patient of either sex.

Exclusion Criteria

1.opium addicted patients who are suffering from major psychiatric disorder.opium addicted patients suffering from major systemic illness like myocardial infarction,ischemic heart disease,hypertension,HIV,cancer,liver failure and renal toxicity.

2.patient undergoing any other drug therapy.

3.pregnant woman.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the clinical efficacy of vishtindukadi vati & mansayadi kwatha along with Abhyang in the management of opium addictionTimepoint: 21 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the clinical efficacy of vishtindukadi vati & mansayadi kwatha alongwith Abhyang in the management of opium addictionTimepoint: 21 days Changes in sign and symptoms will be Recorded
© Copyright 2025. All Rights Reserved by MedPath